Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KIORA PHARMACEUTICALS INC | 20,000 | reported | 01 Apr 2025 | tx 4+31,028 |
| Contineum Therapeutics, Inc. | 14,954 | reported | 25 Feb 2026 | tx 12+1,037,500−15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 4,400 | 1.26 USD | |
| 24 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 4,400 | 16.02 USD | |
| 25 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 2,700 | 1.26 USD | |
| 25 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 2,700 | 16.02 USD | |
| 24 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 4,400 | 0.00 USD | deriv |
| 25 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 2,700 | 0.00 USD | deriv |
| 11 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 400 | 1.26 USD | |
| 11 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 400 | 16.00 USD | |
| 11 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 400 | 0.00 USD | deriv |
| 30 Jan 2026 | GRANT_AWARD | Contineum Therapeutics, Inc. | 445,000 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 20,000 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |
| 11 Sept 2024 | PURCHASE | KIORA PHARMACEUTICALS INC | 1,250 | 3.68 USD | |
| 01 Jul 2024 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 1,778 | 0.00 USD | deriv |
| 24 May 2024 | GRANT_AWARD | Contineum Therapeutics, Inc. | 285,000 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | KIORA PHARMACEUTICALS INC | 8,000 | 0.00 USD | deriv |